Clinical Trials Logo

Psychosis clinical trials

View clinical trials related to Psychosis.

Filter by:

NCT ID: NCT01027962 Completed - Psychosis Clinical Trials

Intensive Computerized Brain Training (ICBT) in Youth With Early Onset Psychosis (EOP)

Start date: October 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to examine whether an intensive computerized intervention targeted on improving central auditory and visual processing and executive functioning can be implemented in youths aged 10-19 with psychotic spectrum disorders, what developmental modifications are needed particularly for the younger participants, and whether it is possible to develop an appropriate, blinded control intervention.

NCT ID: NCT01015586 Completed - Depression Clinical Trials

Treatment of Alcohol Dependence and Comorbid Bipolar Disorder

Start date: February 2010
Phase: Phase 4
Study type: Interventional

The study will determine if individuals with co-occurring bipolar disorder and alcohol dependence report reduced alcohol consumption, improvement in mood symptoms, and cognitive performance if treated with lamotrigine plus their usual mood stabilizing medications relative to subjects treated with placebo plus usual mood stabilizing medications over a 16 week period.

NCT ID: NCT01011088 Completed - Psychosis Clinical Trials

Paternal Psychosis After Baby Born

PAPABAB
Start date: November 2009
Phase: N/A
Study type: Observational

A large number of studies have investigated the psychological disorders occurred in postpartum women, and found that postpartum psychosis is common in new mothers. However, the situation of paternal psychological status after they had their first baby is not assessed. The investigators hypothesized that they had a high occurrence of paternal psychosis after first baby born. In addition, different factors might influence its onset and development in new fathers.

NCT ID: NCT01004354 Completed - Obesity Clinical Trials

Vitamin D Supplementation in Psychiatric Illnesses

VDSS
Start date: June 2009
Phase: N/A
Study type: Interventional

Children and adolescents with psychiatric illnesses who are treated with medications called second generation antipsychotic agents (SGA) often gain excessive weight during their treatment with these medications. This weight gain may result in the development of features of the metabolic syndrome or frank diabetes mellitus. There is no consensus on the best way to prevent these complications. The investigators' hypothesis is that daily vitamin D supplementation in these patients will result in decreased levels of the markers of metabolic syndrome with associated reduction in waist circumference.

NCT ID: NCT01003132 Completed - Schizophrenia Clinical Trials

Assessing the Effectiveness of Acceptance and Commitment Therapy for Distress Following Psychosis

PACT
Start date: October 2009
Phase: N/A
Study type: Interventional

This research investigates a new talking therapy aimed at helping people to come to terms with the experience of psychosis. The new therapy is called Acceptance and Commitment Therapy for psychosis (PACT). PACT aims to help people: 1. Develop a sense of "mindfulness." Mindfulness allows you to be fully aware of your here-and-now experience, with an attitude of openness and curiosity. It is hoped that this will help reduce the impact of painful thoughts and feelings. 2. Take effective action that is conscious and deliberate, rather than impulsive. It is hoped that this will allow people to be motivated, guided, and inspired by the things that they value in life. It is hoped that PACT will help to reduce the level of distress that individuals diagnosed with psychosis have been experiencing and help them to stay well in the future.

NCT ID: NCT00946491 Completed - Psychosis Clinical Trials

To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers

Start date: April 1987
Phase: Phase 1
Study type: Interventional

To demonstrate the relative bioequivalency of generic Haloperidol tablets versus Haldol in normal volunteers.

NCT ID: NCT00878462 Completed - Psychosis Clinical Trials

An Acceptability Study of Unflavored Asenapine Versus Raspberry Flavored Asenapine in Stable Patients With a Psychotic Disorder (P07010)(COMPLETED)

Start date: June 29, 2005
Phase: Phase 2
Study type: Interventional

This trial was a randomized trial to determine a patient's acceptability of unflavored antipsychotic medication compared to raspberry flavored antipsychotic medication. Patients received 6 total doses of study drug (2 doses of each asenapine formulation) over 3 consecutive days: 2 different formulations each day, 1 in the morning and 1 in the evening. The formulations were: white unflavored, white raspberry flavored, and red raspberry flavored. Patients were given a questionnaire following each dose of study medication (one questionnaire twice per day for 3 days) to measure how acceptable each formulation was.

NCT ID: NCT00872313 Completed - Psychosis Clinical Trials

Risk Factors for Postpartum Psychosis

RIFPP
Start date: February 2009
Phase: N/A
Study type: Observational

A range of psychological disorders occur in women in the postpartum period. These include "the blues", which occurs in the first days after birth and which is very common and self-limiting; severe psychoses often associated with mania or bipolar illness, occurring in the first weeks after birth; and mild to moderate depression, occurring weeks to months after birth. Studies have been done focused on postpartum psychosis using a retrospective investigation, which gave only a limited material on the prevalence of psychological disorders in postpartum women. The investigators hypothesized that different pathways to psychosis function as the risk factors which may be overlapped, truly independent, mediating, or moderating, in new mothers who are at high risk and/or during the early period of delivery. In addition, the investigators purposed that the temporal sequence of biological, social and demographic variables are also the potential factors contributing to the development of postpartum psychosis.

NCT ID: NCT00780585 Completed - Psychosis Clinical Trials

A Follow up Safety Study of Patients Who Participated in Previous Studies of the Drug Org 24448 (Study P05719)(COMPLETED)

Start date: April 2007
Phase: N/A
Study type: Observational

This is a safety study evaluating the subjects who participated in previous Organon trials of the drug Org 24448. Patients will undergo a Screening visit, 1 or 2 Evaluation visits, and a possible Follow-Up period. During the visits, study tests, including echocardiograms, will be performed to summarize cardiac functioning.

NCT ID: NCT00680888 Completed - Psychosis Clinical Trials

Adherence in Adolescents and Children Treated on Quetiapine

Start date: August 2005
Phase: N/A
Study type: Observational

Observational study aimed to describe the adherence in a population of adolescents and children treated on quetiapine from a first psychotic episode whose more important secondary objective is to identify possible predictive factors influencing the adherence to treatment with Quetiapine